[EN] COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN TREATING NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉS, COMPOSITION PHARMACEUTIQUE ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
申请人:UNIV LILLE II DROIT & SANTE
公开号:WO2015193255A1
公开(公告)日:2015-12-23
The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
本发明涉及公式(I)的新化合物,以及其药用盐或溶剂和它们的用途。
PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS
申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP1799645A2
公开(公告)日:2007-06-27
AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES
申请人:AstraZeneca AB
公开号:EP2094646A1
公开(公告)日:2009-09-02
COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN TREATING NEURODEGENERATIVE DISEASES
申请人:Université de Lille 2 Droit et Santé
公开号:EP3154934A1
公开(公告)日:2017-04-19
[EN] PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS<br/>[FR] PROCEDES ET PRODUITS INTERMEDIAIRES PERMETTANT DE PREPARER DES INHIBITEURS DE LA CYSTEINE PROTEASE
申请人:AXYS PHARM INC
公开号:WO2006034004A2
公开(公告)日:2006-03-30
The present invention is directed to a process for preparing certain cysteine protease inhibitors.